Natural infection isn't enough to protect against COVID-19,

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks
216
Natural infection isn't enough to protect against COVID-19, experts say. You still need a vaccine.

Adrianna Rodriguez
USA TODAY

https://www.usatoday.com/story/news/health/20...535920001/

As concerned friends and family members try to convince loved ones to get vaccinated, many are met with the argument: "I already got COVID, so I can't get it again."

Health experts say that just isn't true.

Although antibodies from natural infection may provide some protection against the virus, evidence shows nothing protects against COVID-19 better than vaccines.

People who have recovered from COVID-19 should get vaccinated to reduce their risk of reinfection, which will prevent transmission and suppress the opportunity for more variants – like the highly contagious delta – to emerge.

“Natural infection will cause your immune system to make many types of antibodies and immune response to all parts of the virus, but only a small fraction of that response is actually protective,” said Nicole Iovine, chief hospital epidemiologist at University of Florida Health in Gainesville.

“When you get the vaccine, the entire response is targeted to the virus's spike protein.”

A study published Friday by the Centers for Disease Control and Prevention found unvaccinated people who have had COVID-19 are more than twice as likely to be reinfected with the virus compared with people who were fully vaccinated after contracting the virus.

The study included hundreds of Kentucky residents with previous COVID-19 infections from May through June. It showed those who were unvaccinated were 2.34 times more likely to be reinfected compared with those who were fully vaccinated.

“If you have had COVID-19 before, please still get vaccinated,” CDC Director Rochelle Walensky said in a statement. “This study shows you are twice as likely to get infected again if you are unvaccinated. Getting the vaccine is the best way to protect yourself and others around you, especially as the more contagious delta variant spreads around the country.”

Anyone can be at risk for reinfection, health experts said, regardless of age or health status.

'A surge of straight stupidity': The vaccinated are angry. That's understandable but unproductive, health experts say

Will COVID-19 vaccine booster shots be needed? It's likely, experts say, but the immunocompromised should be prioritized.

A study in April published in The Lancet Respiratory Medicine found multiple COVID-19 reinfections in the U.S. Marines Corps, a population considered to be the picture of health. Among the 189 Marines who were infected from May to November 2020, 10% tested positive again.

People reinfected with the virus are more likely to be asymptomatic, which increases the chances of spread, said Michael Grosso, chief medical officer and chair of pediatrics at Northwell Health’s Huntington Hospital in Long Island, New York.

“Individuals who have partial immunity, and therefore susceptible to asymptomatic infection, absolutely place people around them at risk because they don’t know they’re ill, and we know now that they can transmit COVID under those conditions,” he said.

Those with asymptomatic infection can unknowingly expose friends or loved ones who may be older or have weakened immune systems, health experts said, putting them at risk of infection if they’re vaccinated, or worse, at risk of severe disease and death if they’re unvaccinated.


Although most people present milder symptoms during their second bout of COVID-19, Iovine said she's seen a fair share of hospitalizations.

A 25-year-old man in Nevada was the first reported case of COVID-19 reinfection in October 2020, according to a case study published in The Lancet Infectious Diseases. Researchers said his second go-around was “symptomatically more severe than the first.”

Spreading the disease gives the virus more opportunity to mutate, heath experts said, allowing more variants to emerge. According to the CDC, the delta variant accounts for more than 90% of sequenced cases in the USA.

“With this delta variant, you want to have the odds in your favor,” Iovine said. “You don’t want to leave yourself with excess risk, and that’s where vaccination is going to give you that extra layer of protection that natural infection cannot.”


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Resorts World NYC Unveils Luxe High-Roller Room

Updated Category News Views 6

New Frontier for New York's Gaming Scene The glitz and glamour of high-roller gaming just found a new home in the heart of Queens. Resorts World New York City (RWNYC), which has been turning heads for over a decade, has now cranked the luxe up a notch with the introduction of its International Room. This isn't just any room, folks; we're talking about a high-limit gaming...

Continue Reading
Voter Power Flexes with Early Voting Celebrations

Updated Category News Views 16

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 8

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
Rakuten Medical's Long-Term Data Shows Promise

Updated Category News Views 4

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 3

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Venture Dock Fosters Global Startup Ecosystems

Updated Category News Views 6

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 3

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
California Waste Solutions: Investing in Vietnam's Future

Updated Category News Views 3

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Continue Reading
Kahn Swick & Foti Questions Valaris Transocean Deal

Updated Category News Views 6

Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...

Continue Reading

Top 5 Most Recently Viewed Articles

Nasdaq Inc. Reveals Strategy for Cash Tender Offers on Debt

Updated Category News Views 117

Nasdaq Inc. Cash Tender Offers Overview Nasdaq, Inc. (NASDAQ: NDAQ) has made headlines with its recent announcements regarding cash tender offers for up to $218 million of its outstanding debt securities. This initiative involves a strategy to repurchase existing Notes, which consist of senior notes due in 2028, 2034, and 2052. The company has decided to enhance the...

Continue Reading
Ultima Markets Partners with Inter for Exciting New Venture

Updated Category News Views 166

Ultima Markets Partners with Inter in Asia Ultima Markets has officially joined forces with FC Internazionale Milano (Inter) as their Official Regional Partner in Asia. This partnership marks a significant step in Ultima Markets' growth strategy, symbolizing a unique collaboration that merges the world of finance with the excitement of football, creating a distinctive...

Continue Reading
Ribo Secures EMA Orphan Drug Status for RBD1016 Against HDV

Updated Category News Views 191

Ribo Life Science Gains Important EMA Approval BEIJING and GOTHENBURG, Sweden – In a significant advancement for the medical community, Suzhou Ribo Life Science Co., Ltd. along with Ribocure Pharmaceuticals AB has achieved a noteworthy milestone. The European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) for RBD1016, a promising therapeutic aimed at...

Continue Reading
Projected Growth of the Wood Pellets Market Driving Investment

Updated Category News Views 92

Overview of the Wood Pellets Market Growth The latest insights reveal that the wood pellets market is on a trajectory to significantly grow, with projections indicating it could reach an impressive valuation of USD 20.5 billion. This growth is primarily fueled by the rising global demand for renewable energy sources, a trend that is transforming the energy landscape. Key...

Continue Reading
Surge Copper Corp. Engages Investors in Virtual Conference

Updated Category News Views 131

Engagement Opportunity with Surge Copper Corp. Surge Copper Corp. (TSXV: SURG, OTCQB: SRGXF) is set to engage with investors at an upcoming virtual investor conference. This event, held through VirtualInvestorConferences.com, will be hosted by Leif Nilsson, the company's CEO, providing a platform for potential investors to learn more about Surge's ongoing projects focused...

Continue Reading